Skip to content
10-Q

Quarterly Report

CuraScientific Corp.

0001877788-23-000019

← back to feed
Filed
May 12, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · May 10, 2023 6.99M sh
Operating Cash Flow Q1 2023 · Mar 31, 2023 $372
Operating Cash Flow Q1 2023 · Mar 31, 2022 −$151.17K
Cash And Equivalents Q1 2023 · Mar 31, 2023 $502
Cash And Equivalents Q1 2023 · Dec 31, 2022 $130
Cash And Equivalents Q1 2023 · Mar 31, 2022 $2.68K
Cash And Equivalents Q1 2023 · Dec 31, 2021 $23.36K
Stockholders Equity Q1 2023 · Mar 31, 2023 −$70.01M
Stockholders Equity Q1 2023 · Dec 31, 2022 −$69.51M
Stockholders Equity Q1 2023 · Mar 31, 2022 −$71.03M
Stockholders Equity Q1 2023 · Dec 31, 2021 −$69.39M
Current Liabilities Q1 2023 · Mar 31, 2023 $71.14M
Current Liabilities Q1 2023 · Dec 31, 2022 $70.81M
Total Liabilities Q1 2023 · Mar 31, 2023 $71.39M
Total Liabilities Q1 2023 · Dec 31, 2022 $71.06M
Current Assets Q1 2023 · Mar 31, 2023 $27.56K
Current Assets Q1 2023 · Dec 31, 2022 $39.87K
Total Assets Q1 2023 · Mar 31, 2023 $1.39M
Total Assets Q1 2023 · Dec 31, 2022 $1.55M
Sga Expense Q1 2023 · Mar 31, 2023 $19.29K
Sga Expense Q1 2023 · Mar 31, 2022 $140.69K
Net Income Q1 2023 · Mar 31, 2023 −$216.26K
Net Income Q1 2023 · Mar 31, 2022 −$4.57M
Operating Income Q1 2023 · Mar 31, 2023 −$300.5K
Operating Income Q1 2023 · Mar 31, 2022 −$589.37K
Revenue Q1 2023 · Mar 31, 2023 $0
Revenue Q1 2023 · Mar 31, 2022 $25.45K
Capex Q1 2023 · Mar 31, 2022 $14.91K
Gross Profit Q1 2023 · Mar 31, 2022 $17.17K
Cost Of Revenue Q1 2023 · Mar 31, 2022 $8.29K